In addition, patients with high tumoral SR‐B1 expression as profiled by publically available Gene Expression Omnibus (GEO) databases and The Cancer Genome Atlas (TCGA) databases had significantly reduced overall survival compared to patients with low SR‐B1 expression (p = 0.029; Figure S1D, Supporting Information). This evidence concerns the gene SCARB1 and cancer.